Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1

Douglas Lake, M. L. Salgaller, P. Van Der Bruggen, R. M. Bernstein, J. J. Marchalonis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The TCR is responsible for the specificity of cytotoxic T lymphocytes (CTL) by recognizing peptides presented in the context of MHC. By producing recombinant soluble TCR, it is possible to study this interaction at the molecular level. We generated single-chain TCR (scTCR) from tumor infiltrating lymphocytes (TIL) and one CTL clone directed against melanoma-associated antigen (MAGE)-1. Sixty-eight day anti-MAGE-1 TIL and one cloned anti-MAGE-1 CTL were analyzed by PCR for their V(α) and V(β) gene usage. The TIL population showed a restriction in V(α) and V(β) usage with only V(α)4 and V(α)9 and V(β)2 and V(β)7 expressed. The anti-MAGE-1 CTL clone demonstrated absolute restriction with only V(α)12 and V(β)1 expressed. DNA sequence analysis was performed on all V regions, For the TIL, each possible V(α)-V(β) combination (i.e. V(α)4-V(β)2, V(α)9-V(β)2, V(α)4-V(β)7 and V(α)9-V(β)7) was constructed as a distinct scTCR and the recombinant proteins expressed in bacteria. From the anti-MAGE-1 TIL, V(α)4-V(β)2 scTCR demonstrated binding activity to HLA-A1+ cells pulsed with MAGE-1 peptide. Results obtained from screening a panel of our scTCR constructs on HLA-A1+ cells pulsed with MAGE-1 peptide or irrelevant peptide demonstrated that V(β)2 plays a significant role in binding to the MAGE-1 peptide. Amino acid alignment analysis showed that each V(β) sequence is distinctly different from the others. These findings demonstrate that soluble TCR in single-chain format have binding activity. Furthermore, the results indicate that in TCR, like antibodies, one chain may contribute a dominant portion of the binding activity.

Original languageEnglish (US)
Pages (from-to)745-751
Number of pages7
JournalInternational Immunology
Volume11
Issue number5
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Melanoma-Specific Antigens
Tumor-Infiltrating Lymphocytes
Cytotoxic T-Lymphocytes
Clone Cells
HLA-A1 Antigen
Peptides
DNA Sequence Analysis
Recombinant Proteins
Bacteria
Amino Acids
Polymerase Chain Reaction
Antibodies

Keywords

  • Single chain TCR

ASJC Scopus subject areas

  • Immunology

Cite this

Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1. / Lake, Douglas; Salgaller, M. L.; Van Der Bruggen, P.; Bernstein, R. M.; Marchalonis, J. J.

In: International Immunology, Vol. 11, No. 5, 1999, p. 745-751.

Research output: Contribution to journalArticle

@article{89f4f3e10e2047ef96c60346153676fd,
title = "Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1",
abstract = "The TCR is responsible for the specificity of cytotoxic T lymphocytes (CTL) by recognizing peptides presented in the context of MHC. By producing recombinant soluble TCR, it is possible to study this interaction at the molecular level. We generated single-chain TCR (scTCR) from tumor infiltrating lymphocytes (TIL) and one CTL clone directed against melanoma-associated antigen (MAGE)-1. Sixty-eight day anti-MAGE-1 TIL and one cloned anti-MAGE-1 CTL were analyzed by PCR for their V(α) and V(β) gene usage. The TIL population showed a restriction in V(α) and V(β) usage with only V(α)4 and V(α)9 and V(β)2 and V(β)7 expressed. The anti-MAGE-1 CTL clone demonstrated absolute restriction with only V(α)12 and V(β)1 expressed. DNA sequence analysis was performed on all V regions, For the TIL, each possible V(α)-V(β) combination (i.e. V(α)4-V(β)2, V(α)9-V(β)2, V(α)4-V(β)7 and V(α)9-V(β)7) was constructed as a distinct scTCR and the recombinant proteins expressed in bacteria. From the anti-MAGE-1 TIL, V(α)4-V(β)2 scTCR demonstrated binding activity to HLA-A1+ cells pulsed with MAGE-1 peptide. Results obtained from screening a panel of our scTCR constructs on HLA-A1+ cells pulsed with MAGE-1 peptide or irrelevant peptide demonstrated that V(β)2 plays a significant role in binding to the MAGE-1 peptide. Amino acid alignment analysis showed that each V(β) sequence is distinctly different from the others. These findings demonstrate that soluble TCR in single-chain format have binding activity. Furthermore, the results indicate that in TCR, like antibodies, one chain may contribute a dominant portion of the binding activity.",
keywords = "Single chain TCR",
author = "Douglas Lake and Salgaller, {M. L.} and {Van Der Bruggen}, P. and Bernstein, {R. M.} and Marchalonis, {J. J.}",
year = "1999",
doi = "10.1093/intimm/11.5.745",
language = "English (US)",
volume = "11",
pages = "745--751",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1

AU - Lake, Douglas

AU - Salgaller, M. L.

AU - Van Der Bruggen, P.

AU - Bernstein, R. M.

AU - Marchalonis, J. J.

PY - 1999

Y1 - 1999

N2 - The TCR is responsible for the specificity of cytotoxic T lymphocytes (CTL) by recognizing peptides presented in the context of MHC. By producing recombinant soluble TCR, it is possible to study this interaction at the molecular level. We generated single-chain TCR (scTCR) from tumor infiltrating lymphocytes (TIL) and one CTL clone directed against melanoma-associated antigen (MAGE)-1. Sixty-eight day anti-MAGE-1 TIL and one cloned anti-MAGE-1 CTL were analyzed by PCR for their V(α) and V(β) gene usage. The TIL population showed a restriction in V(α) and V(β) usage with only V(α)4 and V(α)9 and V(β)2 and V(β)7 expressed. The anti-MAGE-1 CTL clone demonstrated absolute restriction with only V(α)12 and V(β)1 expressed. DNA sequence analysis was performed on all V regions, For the TIL, each possible V(α)-V(β) combination (i.e. V(α)4-V(β)2, V(α)9-V(β)2, V(α)4-V(β)7 and V(α)9-V(β)7) was constructed as a distinct scTCR and the recombinant proteins expressed in bacteria. From the anti-MAGE-1 TIL, V(α)4-V(β)2 scTCR demonstrated binding activity to HLA-A1+ cells pulsed with MAGE-1 peptide. Results obtained from screening a panel of our scTCR constructs on HLA-A1+ cells pulsed with MAGE-1 peptide or irrelevant peptide demonstrated that V(β)2 plays a significant role in binding to the MAGE-1 peptide. Amino acid alignment analysis showed that each V(β) sequence is distinctly different from the others. These findings demonstrate that soluble TCR in single-chain format have binding activity. Furthermore, the results indicate that in TCR, like antibodies, one chain may contribute a dominant portion of the binding activity.

AB - The TCR is responsible for the specificity of cytotoxic T lymphocytes (CTL) by recognizing peptides presented in the context of MHC. By producing recombinant soluble TCR, it is possible to study this interaction at the molecular level. We generated single-chain TCR (scTCR) from tumor infiltrating lymphocytes (TIL) and one CTL clone directed against melanoma-associated antigen (MAGE)-1. Sixty-eight day anti-MAGE-1 TIL and one cloned anti-MAGE-1 CTL were analyzed by PCR for their V(α) and V(β) gene usage. The TIL population showed a restriction in V(α) and V(β) usage with only V(α)4 and V(α)9 and V(β)2 and V(β)7 expressed. The anti-MAGE-1 CTL clone demonstrated absolute restriction with only V(α)12 and V(β)1 expressed. DNA sequence analysis was performed on all V regions, For the TIL, each possible V(α)-V(β) combination (i.e. V(α)4-V(β)2, V(α)9-V(β)2, V(α)4-V(β)7 and V(α)9-V(β)7) was constructed as a distinct scTCR and the recombinant proteins expressed in bacteria. From the anti-MAGE-1 TIL, V(α)4-V(β)2 scTCR demonstrated binding activity to HLA-A1+ cells pulsed with MAGE-1 peptide. Results obtained from screening a panel of our scTCR constructs on HLA-A1+ cells pulsed with MAGE-1 peptide or irrelevant peptide demonstrated that V(β)2 plays a significant role in binding to the MAGE-1 peptide. Amino acid alignment analysis showed that each V(β) sequence is distinctly different from the others. These findings demonstrate that soluble TCR in single-chain format have binding activity. Furthermore, the results indicate that in TCR, like antibodies, one chain may contribute a dominant portion of the binding activity.

KW - Single chain TCR

UR - http://www.scopus.com/inward/record.url?scp=0032956872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032956872&partnerID=8YFLogxK

U2 - 10.1093/intimm/11.5.745

DO - 10.1093/intimm/11.5.745

M3 - Article

VL - 11

SP - 745

EP - 751

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 5

ER -